National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy.
PLoS One. 2013 Oct 16;8(10):e78475. doi: 10.1371/journal.pone.0078475. eCollection 2013.
Chronic kidney disease (CKD) independently increases the risk of death and cardiovascular disease (CVD) in the general population. However, the relationship between estimated glomerular filtration rate (eGFR) and CVD/death risk in a general population at low risk of CVD has not been explored so far.
Baseline and longitudinal data of 1465 men and 1459 women aged 35-74 years participating to the MATISS study, an Italian general population cohort, were used to evaluate the role of eGFR in the prediction of all-cause mortality and incident CVD.
Bio-bank stored sera were used to evaluate eGFR at baseline. Serum creatinine was measured on thawed samples by means of an IDMS-calibrated enzymatic method. eGFR was calculated by the CKD-EPI formula.
At baseline, less than 2% of enrolled persons had eGFR < 60 mL/min/1.73 m(2) and more than 70% had a 10-year cardiovascular risk score < 10%. In people 60 or more years old, the first and the last eGFR quintiles (<90 and ≥109 mL/min/1.73 m(2), respectively) were associated to an increased risk for both all-cause mortality (hazard ratio 1.6, 95% confidence interval 1.2-2.1 and 4.3, 1.6-11.7, respectively) and incident CVD (1.6, 1.0-2.4 and 7.0, 2.2-22.9, respectively), even if adjusted for classical risk factors.
These findings strongly suggest that in an elderly, general population at low risk of CVD and low prevalence of reduced renal filtration, even a modest eGFR reduction is related to all-cause mortality and CVD incidence, underlying the potential benefit to this population of considering eGFR for their risk prediction.
慢性肾脏病(CKD)会独立增加普通人群的死亡和心血管疾病(CVD)风险。然而,在 CVD 风险较低的普通人群中,估算肾小球滤过率(eGFR)与 CVD/死亡风险之间的关系尚未得到探索。
使用参与 MATISS 研究的 1465 名男性和 1459 名女性的基线和纵向数据,该研究是一项意大利普通人群队列研究,用于评估 eGFR 在预测全因死亡率和新发 CVD 方面的作用。
生物库储存的血清用于评估基线时的 eGFR。解冻后的样本采用经过 IDMS 校准的酶法测量血清肌酐。使用 CKD-EPI 公式计算 eGFR。
在基线时,不到 2%的入组者的 eGFR<60 mL/min/1.73 m(2),超过 70%的人 10 年心血管风险评分<10%。在 60 岁或以上的人群中,第 1 个和最后 1 个 eGFR 五分位数(<90 和≥109 mL/min/1.73 m(2),分别)与全因死亡率(危险比 1.6,95%置信区间 1.2-2.1 和 4.3,1.6-11.7,分别)和新发 CVD(1.6,1.0-2.4 和 7.0,2.2-22.9,分别)风险增加相关,即使调整了经典风险因素。
这些发现强烈表明,在 CVD 风险低且肾小球滤过率降低的患病率低的老年普通人群中,即使 eGFR 略有下降也与全因死亡率和 CVD 发生率相关,这表明考虑 eGFR 对该人群的风险预测具有潜在益处。